Dear long-term investors please on’t rush into decisions based on the short report!!
sorry for AI translation. Here's my opinion after reading short report and after a few discussions with Gemini. Please comment below your opinion or if I stated wrong facts.
1. The "Veteran Surgeons don't need Liberty" argument
The claim that veteran doctors don't feel the need for Liberty was already a known factor to me. However, not every surgeon is a veteran with god-like manual dexterity. Vascular catheterization is a field dominated by "tactile sensitivity," and that is exactly where the robotic opportunity lies. The company’s target shouldn't be the old pros; they should focus on young doctors and residents—training them on the system early to "standardize" their workflow with Liberty.
2. Guidewire Compatibility (0.014" vs. 0.018" standard)
The report asks: "If your target market is peripheral vascular intervention, why is it only compatible with 0.014-inch wires?" (Note: 0.014" is typically for microvessels, while 0.018" is for thicker peripheral vessels).
My rebuttal:
- The Value of Precision: The robot’s value shines even brighter in complex, thin-vessel (0.014") procedures where human hands struggle.
- Medical Trends: The trend is moving toward "minimally invasive" procedures in increasingly smaller vessels. Microbot Medical likely anticipates the market shift from 0.018" to 0.014".
- Official Specs: Official documents state compatibility with 0.014"–0.018" wires and 2–3Fr catheters. The report likely took the limitations of one specific module and exaggerated it as a limitation of the entire system.
3. Radiation Exposure Even veteran surgeons cannot ignore a 92% reduction in radiation exposure. It’s a tug-of-war between "cost-saving" and "personal health." Long-term health is a massive incentive for adoption.
4. "Only 1 out of 15 doctors at Tampa General uses it?" The contract with Tampa General was for pre-commercial testing, not a final report card on commercial success.
- Designated PI (Principal Investigator): When a new device is introduced, hospitals don't let everyone use it at once. They assign a Principal Investigator (in this case, Dr. Bruce) to master the device and establish Standard Operating Procedures (SOP).
- Risk Management: If 15 doctors started using it simultaneously before a full launch and even one accident occurred due to inexperience, Liberty would lose all market trust and be permanently ousted. Controlled testing is a sign of a responsible rollout, not a lack of interest.